Skip to main content
Top
Published in: BMC Immunology 1/2010

Open Access 01-12-2010 | Research article

Bystander T cells in human immune responses to dengue antigens

Authors: Duangchan Suwannasaen, Arunrat Romphruk, Chanvit Leelayuwat, Ganjana Lertmemongkolchai

Published in: BMC Immunology | Issue 1/2010

Login to get access

Abstract

Background

Previous studies of T cell activation in dengue infection have focused on restriction of specific T cell receptors (TCRs) and classical MHC molecules. However, bystander T cell activation, which is TCR independent, occurs via cytokines in other viral infections, both in vitro and in vivo, and enables T cells to bypass certain control checkpoints. Moreover, clinical and pathological evidence has pointed to cytokines as the mediators of dengue disease severity. Therefore, we investigated bystander T cell induction by dengue viral antigen.

Results

Whole blood samples from 55 Thai schoolchildren aged 13-14 years were assayed for in vitro interferon-gamma (IFN-γ) induction in response to inactivated dengue serotype 2 antigen (Den2). The contribution of TCR-dependent and independent pathways was tested by treatment with cyclosporin A (CsA), which inhibits TCR-dependent activation of T cells. ELISA results revealed that approximately 72% of IFN-γ production occurred via the TCR-dependent pathway. The major IFN-γ sources were natural killer (NK) (mean ± SE = 55.2 ± 3.3), CD4+T (24.5 ± 3.3) and CD8+T cells (17.9 ± 1.5), respectively, as demonstrated by four-color flow cytometry. Interestingly, in addition to these cells, we found CsA-resistant IFN-γ producing T cells (CD4+T = 26.9 ± 3.6% and CD8+T = 20.3 ± 2.1%) implying the existence of activated bystander T cells in response to dengue antigen in vitro. These bystander CD4+ and CD8+T cells had similar kinetics to NK cells, appeared after 12 h and were inhibited by anti-IL-12 neutralization indicating cytokine involvement.

Conclusions

This study described immune cell profiles and highlighted bystander T cell activation in response to dengue viral antigens of healthy people in an endemic area. Further studies on bystander T cell activation in dengue viral infection may reveal the immune mechanisms that protect or enhance pathogenesis of secondary dengue infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, Khemnu N, Tangthawornchaikul N, Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A, Xu X, Malasit P, Screaton G: T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol. 2006, 176: 3821-3829.CrossRefPubMed Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, Khemnu N, Tangthawornchaikul N, Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A, Xu X, Malasit P, Screaton G: T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol. 2006, 176: 3821-3829.CrossRefPubMed
2.
go back to reference Kurane I, Innis BL, Nisalak A, Hoke C, Nimmannitya S, Meager A, Ennis FA: Human T cell responses to dengue virus antigens: Proliferative responses and interferon gamma production. J Clin Invest. 1989, 83: 506-513. 10.1172/JCI113911.PubMedCentralCrossRefPubMed Kurane I, Innis BL, Nisalak A, Hoke C, Nimmannitya S, Meager A, Ennis FA: Human T cell responses to dengue virus antigens: Proliferative responses and interferon gamma production. J Clin Invest. 1989, 83: 506-513. 10.1172/JCI113911.PubMedCentralCrossRefPubMed
3.
go back to reference Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL: Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002, 185: 1213-1221. 10.1086/340365.CrossRefPubMed Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL: Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002, 185: 1213-1221. 10.1086/340365.CrossRefPubMed
4.
go back to reference Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA: Activation of T lymphocytes in dengue virus infections: High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest. 1991, 88: 1473-1480. 10.1172/JCI115457.PubMedCentralCrossRefPubMed Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA: Activation of T lymphocytes in dengue virus infections: High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest. 1991, 88: 1473-1480. 10.1172/JCI115457.PubMedCentralCrossRefPubMed
5.
go back to reference Mangada MM, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Libraty DH, Green S, Ennis FA, Rothman AL: Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis. 2002, 185: 1697-1703. 10.1086/340822.CrossRefPubMed Mangada MM, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Libraty DH, Green S, Ennis FA, Rothman AL: Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis. 2002, 185: 1697-1703. 10.1086/340822.CrossRefPubMed
6.
go back to reference Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL: Impaired T cell proliferation in acute dengue infection. J Immunol. 1999, 162: 5609-5615.PubMed Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL: Impaired T cell proliferation in acute dengue infection. J Immunol. 1999, 162: 5609-5615.PubMed
7.
go back to reference Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL: T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol. 2002, 168: 5959-5965.CrossRefPubMed Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL: T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol. 2002, 168: 5959-5965.CrossRefPubMed
8.
go back to reference Zhang X, Sun S, Hwang I, Tough DF, Sprent J: Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 1998, 8: 591-599. 10.1016/S1074-7613(00)80564-6.CrossRefPubMed Zhang X, Sun S, Hwang I, Tough DF, Sprent J: Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 1998, 8: 591-599. 10.1016/S1074-7613(00)80564-6.CrossRefPubMed
9.
go back to reference Deshpande S, Zheng M, Lee S, Banerjee K, Gangappa S, Kumaraguru U, Rouse BT: Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol. 2001, 167: 2902-2910.CrossRefPubMed Deshpande S, Zheng M, Lee S, Banerjee K, Gangappa S, Kumaraguru U, Rouse BT: Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol. 2001, 167: 2902-2910.CrossRefPubMed
10.
go back to reference Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ: Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol. 2001, 166: 1097-1105.CrossRefPubMed Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ: Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol. 2001, 166: 1097-1105.CrossRefPubMed
11.
go back to reference Bangs SC, McMichael AJ, Xu XN: Bystander T cell activation--implications for HIV infection and other diseases. Trends Immunol. 2006, 27: 518-524. 10.1016/j.it.2006.09.006.CrossRefPubMed Bangs SC, McMichael AJ, Xu XN: Bystander T cell activation--implications for HIV infection and other diseases. Trends Immunol. 2006, 27: 518-524. 10.1016/j.it.2006.09.006.CrossRefPubMed
12.
go back to reference Smeltz RB: Profound enhancement of the IL-12/IL-18 pathway of IFN-gamma secretion in human CD8+ memory T cell subsets via IL-15. J Immunol. 2007, 178: 4786-4792.CrossRefPubMed Smeltz RB: Profound enhancement of the IL-12/IL-18 pathway of IFN-gamma secretion in human CD8+ memory T cell subsets via IL-15. J Immunol. 2007, 178: 4786-4792.CrossRefPubMed
13.
go back to reference Kim SK, Brehm MA, Welsh RM, Selin LK: Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol. 2002, 169: 90-98.CrossRefPubMed Kim SK, Brehm MA, Welsh RM, Selin LK: Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol. 2002, 169: 90-98.CrossRefPubMed
14.
go back to reference Rowland CA, Lertmemongkolchai G, Bancroft A, Haque A, Lever MS, Griffin KF, Jackson MC, Nelson M, O'Garra A, Grencis R, Bancroft GJ, Lukaszewski RA: Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei. Infect Immun. 2006, 74: 5333-5340. 10.1128/IAI.02046-05.PubMedCentralCrossRefPubMed Rowland CA, Lertmemongkolchai G, Bancroft A, Haque A, Lever MS, Griffin KF, Jackson MC, Nelson M, O'Garra A, Grencis R, Bancroft GJ, Lukaszewski RA: Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei. Infect Immun. 2006, 74: 5333-5340. 10.1128/IAI.02046-05.PubMedCentralCrossRefPubMed
15.
go back to reference Organization WH: Dengue and Dengue Hemorrhagic Fever. Fact Sheet. 2008 Organization WH: Dengue and Dengue Hemorrhagic Fever. Fact Sheet. 2008
16.
go back to reference Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW: Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003, 68: 191-202.PubMed Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW: Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003, 68: 191-202.PubMed
17.
go back to reference Endy TP, Nisalak A, Chunsuttiwat S, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA: Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002, 156: 52-59. 10.1093/aje/kwf006.CrossRefPubMed Endy TP, Nisalak A, Chunsuttiwat S, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA: Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002, 156: 52-59. 10.1093/aje/kwf006.CrossRefPubMed
18.
go back to reference Pang T, Cardosa MJ, Guzman MG: Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007, 85: 43-45. 10.1038/sj.icb.7100008.CrossRefPubMed Pang T, Cardosa MJ, Guzman MG: Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007, 85: 43-45. 10.1038/sj.icb.7100008.CrossRefPubMed
19.
go back to reference Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K: Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol. 1998, 10: 259-264. 10.1016/S0952-7915(98)80163-5.CrossRefPubMed Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K: Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol. 1998, 10: 259-264. 10.1016/S0952-7915(98)80163-5.CrossRefPubMed
20.
go back to reference Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM: IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nature Immunology. 2001, 2: 157-164. 10.1038/84264.CrossRefPubMed Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM: IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nature Immunology. 2001, 2: 157-164. 10.1038/84264.CrossRefPubMed
21.
go back to reference Bofill M, Almirall E, McQuaid A, Pena R, Ruiz-Hernandez R, Naranjo M, Ruiz L, Clotet B, Borras FE: Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA and CD45RO phenotype from tonsils, cord and adult peripheral blood. Clin Exp Immunol. 2004, 138: 460-465. 10.1111/j.1365-2249.2004.02651.x.PubMedCentralCrossRefPubMed Bofill M, Almirall E, McQuaid A, Pena R, Ruiz-Hernandez R, Naranjo M, Ruiz L, Clotet B, Borras FE: Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA and CD45RO phenotype from tonsils, cord and adult peripheral blood. Clin Exp Immunol. 2004, 138: 460-465. 10.1111/j.1365-2249.2004.02651.x.PubMedCentralCrossRefPubMed
22.
go back to reference de Arquer GR, Pena R, Cabrera C, Coma G, Ruiz-Hernandez R, Guerola R, Clotet B, Ruiz L, Este JA, Calle ML, Bofill M: Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients. J Leukoc Biol. 2007, 82: 72-78. 10.1189/jlb.1106698.CrossRefPubMed de Arquer GR, Pena R, Cabrera C, Coma G, Ruiz-Hernandez R, Guerola R, Clotet B, Ruiz L, Este JA, Calle ML, Bofill M: Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients. J Leukoc Biol. 2007, 82: 72-78. 10.1189/jlb.1106698.CrossRefPubMed
23.
go back to reference Paganin C, Frank I, Trinchieri G: Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients. J Clin Invest. 1995, 96: 1677-1682. 10.1172/JCI118209.PubMedCentralCrossRefPubMed Paganin C, Frank I, Trinchieri G: Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients. J Clin Invest. 1995, 96: 1677-1682. 10.1172/JCI118209.PubMedCentralCrossRefPubMed
24.
go back to reference Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Buschenfelde KH, Neurath MF: IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol. 1998, 160: 3642-3647.PubMed Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Buschenfelde KH, Neurath MF: IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol. 1998, 160: 3642-3647.PubMed
25.
go back to reference Liu K, Catalfamo M, Li Y, Henkart PA, Weng NP: IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci USA. 2002, 99: 6192-6197. 10.1073/pnas.092675799.PubMedCentralCrossRefPubMed Liu K, Catalfamo M, Li Y, Henkart PA, Weng NP: IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci USA. 2002, 99: 6192-6197. 10.1073/pnas.092675799.PubMedCentralCrossRefPubMed
26.
go back to reference Wang H, Grzywacz B, Sukovich D, McCullar V, Cao Q, Lee AB, Blazar BR, Cornfield DN, Miller JS, Verneris MR: The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood. 2007, 110: 1530-1539. 10.1182/blood-2006-10-048173.PubMedCentralCrossRefPubMed Wang H, Grzywacz B, Sukovich D, McCullar V, Cao Q, Lee AB, Blazar BR, Cornfield DN, Miller JS, Verneris MR: The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood. 2007, 110: 1530-1539. 10.1182/blood-2006-10-048173.PubMedCentralCrossRefPubMed
27.
go back to reference Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF: NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clinical and experimental immunology. 2006, 143: 345-356. 10.1111/j.1365-2249.2006.02996.x.PubMedCentralCrossRefPubMed Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF: NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clinical and experimental immunology. 2006, 143: 345-356. 10.1111/j.1365-2249.2006.02996.x.PubMedCentralCrossRefPubMed
28.
go back to reference Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Ennis FA, Rothman AL, Green S: Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. The Journal of infectious diseases. 2007, 195: 1108-1116. 10.1086/512860.CrossRefPubMed Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Ennis FA, Rothman AL, Green S: Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. The Journal of infectious diseases. 2007, 195: 1108-1116. 10.1086/512860.CrossRefPubMed
29.
go back to reference Lanier LL, Sun JC: Do the terms innate and adaptive immunity create conceptual barriers?. Nature reviews Immunology. 2009, 9: 302-303. 10.1038/nri2547.PubMedCentralCrossRefPubMed Lanier LL, Sun JC: Do the terms innate and adaptive immunity create conceptual barriers?. Nature reviews Immunology. 2009, 9: 302-303. 10.1038/nri2547.PubMedCentralCrossRefPubMed
30.
go back to reference Mangada MM, Rothman AL: Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol. 2005, 175: 2676-2683.CrossRefPubMed Mangada MM, Rothman AL: Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol. 2005, 175: 2676-2683.CrossRefPubMed
31.
go back to reference Bashyam HS, Green S, Rothman AL: Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol. 2006, 176: 2817-2824.CrossRefPubMed Bashyam HS, Green S, Rothman AL: Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol. 2006, 176: 2817-2824.CrossRefPubMed
32.
go back to reference Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH: An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 1989, 40: 418-427.PubMed Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH: An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 1989, 40: 418-427.PubMed
Metadata
Title
Bystander T cells in human immune responses to dengue antigens
Authors
Duangchan Suwannasaen
Arunrat Romphruk
Chanvit Leelayuwat
Ganjana Lertmemongkolchai
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2010
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-11-47

Other articles of this Issue 1/2010

BMC Immunology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.